Core Viewpoint - The company, Hailiang Co., is planning to issue H-shares and list on the Hong Kong Stock Exchange to enhance its global strategy and international competitiveness [1][2]. Group 1: Global Strategy and Market Position - Hailiang Co. has established long-term stable business relationships with nearly 10,000 customers across over 130 countries and regions, leveraging its global production capacity and technological innovation [1][3]. - The company has become the largest and most competitive manufacturer of copper pipes and rods globally, with a strategic focus on global expansion through self-built and acquired production bases [2][3]. Group 2: Financial Performance - In the first half of 2025, Hailiang Co. achieved a total revenue of 444.76 billion yuan, a year-on-year increase of 1.17%, and a net profit attributable to shareholders of 7.11 billion yuan, up 15.03% [5][7]. - The company's overseas business revenue reached 186.37 billion yuan, reflecting a year-on-year growth of 13.2%, contributing to 41.9% of total revenue [3][5]. Group 3: Research and Development - Hailiang Co. has invested a total of 35.51 billion yuan in research and development over the past four and a half years, with a focus on product and process innovation [6][7]. - As of June 2025, the company holds 915 patents, including 150 invention patents, demonstrating its commitment to technological advancement [7]. Group 4: Asset Growth - The total assets of Hailiang Co. increased from 261.2 billion yuan at the end of 2020 to 473.8 billion yuan by June 2025, marking an increase of 212.6 billion yuan, or over 80% [1][6].

Summary of Key Points Core Viewpoint The announcement from Zhejiang Hailiang Co., Ltd. details the upcoming redemption and cessation of conversion for its convertible bonds, "Hailiang Convertible Bonds," emphasizing the importance for bondholders to act before the final conversion date. Group 1: Important Dates and Actions - The last conversion date for "Hailiang Convertible Bonds" is September 26, 2025, after which unconverted bonds will cease to be convertible [2][4] - The redemption price for the bonds is set at 101.710 CNY per bond, including accrued interest at an annual rate of 2.00% [3][16] - The bonds will stop trading on September 24, 2025, and the redemption registration date is September 26, 2025 [4][20] Group 2: Redemption Conditions and Procedures - The redemption conditions were met on August 25, 2025, allowing the company to exercise its right to redeem the bonds early [5][10] - The bonds will be fully redeemed on September 29, 2025, with funds credited to bondholders' accounts by October 14, 2025 [21][22] - Bondholders must ensure that any pledged or frozen bonds are released before the conversion cessation date to avoid forced redemption [4][25] Group 3: Convertible Bond Details - The total issuance of "Hailiang Convertible Bonds" was 315 million bonds, with a total value of 3.15 billion CNY, issued on November 21, 2019 [5][6] - The initial conversion price was set at 9.83 CNY per share, which has been adjusted multiple times due to annual profit distributions, with the latest adjustment bringing it to 9.20 CNY per share [7][10][9] Group 4: Future Plans for H Shares - The company is planning to issue H shares and list them on the Hong Kong Stock Exchange to enhance its global strategy and competitiveness [27][28] - The specific details of the H share issuance are still under discussion with relevant intermediaries and have not yet been finalized [27][28]

Group 1 - Baiyun Airport announces joint investment with China Duty Free Group to establish a duty-free company with a registered capital of 45 million yuan, where China Duty Free Group holds 51% [3] - Dongxing Medical plans to acquire 90% stake in Wuhan Yijiaobao, a high-tech company focused on orthopedic and biomedical materials [4] - Fosun Pharma's subsidiary plans to transfer 100% stake in Shanghai Clone to enhance asset operation efficiency, with a transaction value of up to 1.256 billion yuan [5] Group 2 - Hengxing Technology's subsidiary is awaiting approval for the extension of mining license for Longtoushan Gold Mine, with exploration activities ongoing [6] - New Sai Co. announces resignation of its general manager Chen Jianjiang due to work adjustments [7] - Hailiang Co. is planning to issue H-shares and list on the Hong Kong Stock Exchange, with details yet to be finalized [8] Group 3 - Zhejiang University Network plans to sell 48.6 million shares of Wanliyang, expecting a transaction amount of 475 million yuan [9] - Huazhong Precision terminates the issuance of A-shares to specific targets, affecting a control acquisition [10] - Jiaze New Energy states that its green chemical business is not yet commercially viable, with no significant impact on revenue or profit in the short term [11] Group 4 - Hailan Home plans to issue H-shares and list on the Hong Kong Stock Exchange, with discussions ongoing with intermediaries [12] - Hongfuhang intends to invest up to 1.128 billion yuan in a joint venture to build a photovoltaic energy storage project in Congo [13] - Zhongchuang Zhiling plans to invest 5 billion yuan in a new energy vehicle parts industrial base and R&D center [14] Group 5 - Haitai Development's subsidiary signs a property sale contract worth 440 million yuan, expected to increase profits by approximately 62.86 million yuan in 2025 [15] - Dongjie Intelligent's overseas subsidiary secures a procurement order worth approximately 180 million yuan, representing 22.3% of its audited revenue for 2024 [17] - Zhiguang Electric's subsidiary signs a procurement contract worth 164 million yuan for energy storage systems [18] Group 6 - ST Songfa's subsidiary signs a shipbuilding contract for four VLCCs, with a contract value between 400 million to 600 million USD [19] - Huaguang Huaneng signs a sales contract for waste heat boilers worth 160 million yuan for a power plant project in Cambodia [20] - Yousheng Co. receives a project notification from a German automaker, with total sales expected to reach approximately 2.3 billion yuan [24] Group 7 - Zai Sheng Technology's controlling shareholder plans to reduce holdings by up to 3% [25] - Compton plans to reduce holdings of repurchased shares by up to 1% [26] - Aored plans to reduce holdings of repurchased shares by up to 1.29% [27] Group 8 - Xianhe Co. plans to raise up to 3 billion yuan through a private placement for a new materials project [34] - Guanshi Technology plans to raise up to 700 million yuan for photomask manufacturing and other projects [33] - Beilu Pharmaceutical plans to raise up to 300 million yuan for production facility upgrades and working capital [34]

Major Events - Baiyun Airport announced a joint investment with China Duty Free Group to establish a duty-free company at Guangzhou Baiyun Airport with a registered capital of 45 million yuan, where China Duty Free will contribute 22.95 million yuan for a 51% stake [4] - Dongxing Medical plans to acquire 90% of Wuhan Yijiaobao's equity for cash, which is expected to constitute a major asset restructuring [5] - Fosun Pharma's subsidiary is planning to transfer 100% of Shanghai Clon to enhance asset operation efficiency, with a transaction value of up to 1.256 billion yuan [7] - Hengxing Technology's subsidiary is undergoing a review for the extension of mining license for Longtoushan Gold Mine, with exploration activities ongoing [8] - New Sai Co.'s general manager Chen Jianjiang resigned due to work adjustments [9] - Hailiang Co. is planning to issue H-shares and list on the Hong Kong Stock Exchange, with details yet to be finalized [10] - Zhejiang University Net announced plans to sell 48.6 million shares of Wanliyang, expecting a transaction amount of 475 million yuan [11] - Huazhong Precision terminated its plan to issue A-shares to specific investors, which also halts the acquisition of control by a third party [12] - Jiazhe New Energy stated that its green chemical business is not yet commercially viable [13] Significant Contracts - Haitai Development's subsidiary signed a property sale contract worth 440 million yuan, expected to increase profits by approximately 62.86 million yuan in 2025 [18] - Dongjie Intelligent's overseas subsidiary received a procurement order worth approximately 180 million yuan, accounting for 22.3% of the company's audited revenue for 2024 [19][20] - Zhiguang Electric's subsidiary signed a procurement contract worth 164 million yuan for energy storage systems [21] - ST Songfa's subsidiary signed contracts for building four oil tankers, with a total value between 400 million to 600 million USD [22] - Huaguang Huaneng signed a sales contract for waste heat boilers worth 160 million yuan for a power plant project in Cambodia [23] - Keda Intelligent plans to issue H-shares and list on the Hong Kong Stock Exchange, with details still under discussion [24] Shareholding Changes - Zai Sheng Technology's controlling shareholder plans to reduce holdings by up to 3% [28] - Compton plans to reduce up to 1% of its repurchased shares [29] - Aorede plans to reduce up to 1.29% of its shares from the repurchased stock [30] - Yidian Tianxia's controlling shareholder plans to reduce up to 3% of its shares [31] - Huace Film's shareholders plan to transfer 3.6% of the company's shares through an inquiry transfer [32] Buybacks and Financing - Qibin Group obtained a special financing support of up to 90 million yuan for share repurchase [33] - CanSino plans to cancel 406,100 repurchased shares and reduce registered capital accordingly [35] Fundraising Initiatives - Xianhe Co. plans to raise up to 3 billion yuan through a private placement for a high-performance paper-based new materials project [36] - Guanshi Technology plans to raise up to 700 million yuan for photomask manufacturing and other projects [37] - Beilu Pharmaceutical plans to raise up to 300 million yuan for production line upgrades and working capital [38]

Joint Ventures and Investments - Baiyun Airport announced a joint investment with China Duty Free Group to establish a duty-free company with a registered capital of 45 million yuan, where China Duty Free Group holds a 51% stake [3] - Dongxing Medical plans to acquire 90% of Wuhan Yijiaobao Biological Materials Co., a high-tech enterprise focused on orthopedic and biomedical materials [4] - Fosun Pharma's subsidiary is planning to transfer 100% of Shanghai Cloning's equity to enhance asset operation efficiency, with a transaction value of up to 1.256 billion yuan [5] Corporate Actions - New Sai Co. announced the resignation of its director and general manager, Chen Jianjiang, due to work adjustments [7] - Hailiang Co. is planning to issue H-shares and list on the Hong Kong Stock Exchange, with discussions ongoing with intermediaries [8] - Zhejiang University Network New plans to sell 48.6 million shares of Wanliyang, expecting a transaction amount of 475 million yuan [9] Contracts and Orders - Haitai Development's subsidiary signed a property sale contract worth 440 million yuan, expected to increase the company's profit by approximately 62.86 million yuan in 2025 [12] - Dongjie Intelligent's overseas subsidiary received a procurement order worth approximately 180 million yuan, accounting for 22.3% of the company's audited revenue for 2024 [13] - Zhiguang Electric's subsidiary signed a procurement contract worth 164 million yuan for high-voltage energy storage systems [14] - ST Songfa's subsidiary signed contracts for the construction of four oil tankers, with a total contract value between 400 million to 600 million USD [15] - Huaguang Huaneng signed a sales contract for waste heat boilers worth 160 million yuan for a power plant project in Cambodia [16] Regulatory and Compliance - Jingliang Holdings received an administrative regulatory decision from Hainan Securities Regulatory Bureau for violations related to trade activities, involving an income amount of 299 million yuan [18] Shareholder Actions - Zaiseng Technology's controlling shareholder plans to reduce its stake by up to 3%, amounting to approximately 30.9 million shares [20] - Compton plans to reduce its repurchased shares by up to 1%, totaling approximately 2.5644 million shares [21] Financing Activities - Qibin Group obtained a special financing support of up to 90 million yuan for share repurchase from Industrial and Commercial Bank of China [23] - Xianhe Co. plans to raise up to 3 billion yuan through a private placement for a high-performance paper-based new materials project [25]

格隆汇9月26日丨海亮股份(002203.SZ)公布，根据浙江海亮股份有限公司总体发展战略及运营需要，为 深入推进全球化战略，提升公司国际形象及综合竞争力，加强与境外资本市场对接，公司拟筹划在境外 发行股份（H股）并在香港联合交易所有限公司（下称"香港联交所"）主板挂牌上市。截至目前，公司 正计划与相关中介机构就本次H股发行上市的相关工作进行商讨，相关细节尚未最终确定。 ...

格隆汇9月26日｜浙江海亮股份有限公司发布公告，基于总体发展战略及运营需要，为深入推进全球化 战略等，公司拟筹划境外发行H股并在香港联交所主板挂牌上市。截至目前，正计划与相关中介机构商 讨相关工作，细节未确定。待确定具体方案后，本次H股发行上市需经公司董事会和股东会审议，还需 取得中国证监会、香港联交所等相关政府及监管机构备案、批准或核准，最终能否实施存在较大不确定 性。 ...

人民财讯9月26日电，海亮股份（002203）9月26日公告，公司筹划在境外发行股份(H股)并在香港联交 所主板挂牌上市。截至目前，公司正计划与相关中介机构就此次H股发行上市的相关工作进行商讨，相 关细节尚未最终确定。 ...

每经AI快讯，9月26日，海亮股份（002203）(002203.SZ)公告称，公司拟筹划在境外发行股份(H股)并 在香港联合交易所有限公司主板挂牌上市。 ...

| 证券代码：002203 | 证券简称：海亮股份 | 公告编号：2025-099 | | --- | --- | --- | | 债券代码：128081 | 债券简称：海亮转债 | | 特此公告 浙江海亮股份有限公司 董事会 二〇二五年九月二十七日 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 根据浙江海亮股份有限公司（下称"公司"）总体发展战略及运营需要，为 深入推进全球化战略，提升公司国际形象及综合竞争力，加强与境外资本市场 对接，公司拟筹划在境外发行股份（H 股）并在香港联合交易所有限公司（下 称"香港联交所"）主板挂牌上市（下称"本次 H 股发行上市"）。截至目前，公 司正计划与相关中介机构就本次 H 股发行上市的相关工作进行商讨，相关细节 尚未最终确定。 根据《中华人民共和国公司法》《中华人民共和国证券法》《深圳证券交易 所股票上市规则》《境内企业境外发行证券和上市管理试行办法》《香港联合交 易所有限公司证券上市规则》以及中国香港法律对在中国境内注册成立的发行 人在香港发行股票并上市等相关法律法规的要求，待确定具体方案后，本次 H 股发行上市尚需 ...